-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Alibaba Health Information Technology Limited (HKG:241) Insiders Placed Bullish Bets Worth CN¥8.7m in the Last 12 Months
Alibaba Health Information Technology Limited (HKG:241) Insiders Placed Bullish Bets Worth CN¥8.7m in the Last 12 Months
In the last year, multiple insiders have substantially increased their holdings of Alibaba Health Information Technology Limited (HKG:241) stock, indicating that insiders' optimism about the company's prospects has increased.
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
See our latest analysis for Alibaba Health Information Technology
Alibaba Health Information Technology Insider Transactions Over The Last Year
In the last twelve months, the biggest single purchase by an insider was when COO & Executive Director Difan Shen bought HK$4.5m worth of shares at a price of HK$7.54 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being HK$4.70). While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Notably Difan Shen was also the biggest seller.
Over the last year, we can see that insiders have bought 1.17m shares worth HK$8.7m. But insiders sold 21.39k shares worth HK$108k. In total, Alibaba Health Information Technology insiders bought more than they sold over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
SEHK:241 Insider Trading Volume August 15th 2022Alibaba Health Information Technology is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
Insiders At Alibaba Health Information Technology Have Sold Stock Recently
We have seen a bit of insider selling at Alibaba Health Information Technology, over the last three months. Insiders sold just HK$108k worth of shares in that time. It's not great to see insider selling, nor the lack of recent buyers. But the selling simply isn't sufficiently substantial to be of much use as a signal.
Insider Ownership Of Alibaba Health Information Technology
For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that Alibaba Health Information Technology insiders own 5.8% of the company, worth about HK$3.7b. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
So What Do The Alibaba Health Information Technology Insider Transactions Indicate?
Insiders sold Alibaba Health Information Technology shares recently, but they didn't buy any. On the other hand, the insider transactions over the last year are encouraging. We are also comforted by the high levels of insider ownership. So we're happy to look past recent trading. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Every company has risks, and we've spotted 1 warning sign for Alibaba Health Information Technology you should know about.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
去年,多家內部人士大幅增持了阿里健康有限公司(HKG:241)股票,顯示內部人士對公司前景的樂觀情緒有所增加。
儘管就長期投資而言,內幕交易並不是最重要的事情,但從邏輯上講,你應該關注內部人士是在買入還是賣出股票。
參見我們對阿里健康的最新分析
阿里健康過去一年的內幕交易
過去12個月,內部人士買入的最大單筆交易是董事首席運營官沈迪凡以每股7.54港元的價格購入價值450萬港元的股票。因此,很明顯,一名內部人士想要收購,即使價格高於目前的股價(4.70港元)。儘管他們的觀點可能在收購後發生了變化,但這至少表明他們對公司的未來充滿信心。我們總是仔細注意內部人士購買股票時支付的價格。一般來説,如果內部人士以高於當前價格的價格買入一隻股票,我們對這隻股票的看法會更積極,因為這表明他們認為這隻股票很有價值,即使價格更高。值得注意的是,沈迪凡也是最大的賣家。
過去一年,我們可以看到,內部人士購買了117萬股股票,價值870萬港元。但內部人士拋售了21.39萬股,價值10.8萬港元。過去一年,阿里健康內部人士總共買多賣少。你可以在下面看到過去12個月(由公司和個人)進行的內幕交易的直觀描述。如果你想知道到底是誰賣了,賣了多少錢,什麼時候賣的,只需點擊下面的圖表!
聯交所:241宗內幕交易量2022年8月15日內部人士買入的股票並非只有阿里健康一隻。對於那些想要找到贏得投資這免費最近有內幕收購的不斷增長的公司名單可能就是合適的選擇。
阿里健康的內部人士最近拋售了股票
在過去的三個月裏,我們看到了阿里健康的一些內幕出售行為。在此期間,內部人士僅出售了價值10.8萬港元的股票。看到內幕銷售或缺少最近的買家都不是件好事。但拋售的規模還不夠大,不足以作為一個信號發揮作用。
阿里健康的內部人所有權
對於一個普通股股東來説,公司內部人士持有多少股份值得一查。通常,內部人持股越高,內部人就越有可能受到激勵,建立長期的公司。很高興看到阿里健康的內部人士持有該公司5.8%的股份,價值約37億港元。大多數股東將樂於看到這種內部人持股,因為這表明管理層的激勵與其他股東很好地結合在一起。
那麼,阿里健康內幕交易意味着什麼呢?
內部人士最近賣出了阿里健康的股票,但他們一股也沒買。另一方面,過去一年的內幕交易令人鼓舞。我們還對高水平的內部人持股感到欣慰。因此,我們很高興回顧一下最近的交易。因此,這些內幕交易可以幫助我們建立一個關於股票的論文,但瞭解這家公司面臨的風險也是值得的。每家公司都有風險,我們已經發現阿里健康的1個警示標誌你應該知道。
如果你更願意看看另一家公司--一家財務狀況可能更好的公司--那麼不要錯過這一點免費列出了一些有趣的公司,這些公司擁有高股本回報率和低債務。
就本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前負責公開市場交易和私人處置,但不包括衍生品交易。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧